FDA approves Ironwood’s gout combination drug
arthritis, AstraZeneca, FDA approvals 2017, gout, Ironwood Pharmaceuticals
0 Comment
Good news for Ironwood, which forecast annual sales of up to $300m, despite black box kidney failure warning.